# Colchicine and Inflammation in Aortic Stenosis

Study · id `cardio:ct-nct05162742` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05162742](<https://clinicaltrials.gov/study/NCT05162742>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05162742

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

## Technical summary

Registry record NCT05162742. Randomized; quadruple masking; primary purpose treatment. Start 2022-12-22 (actual); primary completion 2026-12 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT05162742, source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)
- Started: 2022-12-22 (actual) (ClinicalTrials.gov record NCT05162742, source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)
- Primary completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05162742, source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)
- Completion: 2026-12 (anticipated) (ClinicalTrials.gov record NCT05162742, source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT05162742, source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05162742-2026-08-27`, retrieved 2026-10-26)

## The registry's words

- Brief title: Colchicine and Inflammation in Aortic Stenosis
- Acronym: CHIANTI
- Condition: Aortic Valve Disease
- Condition: Aortic Valve Stenosis
- Condition: Aortic Valve Calcification
- Condition: Inflammation
- Condition: Calcification
- Condition: Cardiovascular Diseases
- Intervention (Drug): Colchicine
- Intervention (Drug): Placebo
- Lead sponsor: Radboud University Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry intervention name matches this record: Colchicine (`cardio:colchicine`)
- Registry lists this organization as the lead sponsor: Radboud University Medical Center (`cardio:org-radboud-university-medical-center`)

## Provenance

Content hash: d6ffb1db47837edd587336648f5972ea49187a549338a3ff0d0f9bf53c815e82
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
